Related Experiment Video
Updated: Jul 1, 2026

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
The mechanism for ligand activation of the Smoothened G protein-coupled receptor
Ryan D Yu1, Amy-Doan P Vo1, Soo-Kyung Kim1
1Materials and Process Simulation Center, Division of Chemistry & Chemical Engineering, California Institute of Technology, Pasadena, CA 91125.
Abstract:
The Smoothened (SMO) G protein-coupled receptor is a key part of the Hedgehog (Hh) signaling pathway, and it is an oncoprotein that is an important target for understanding cancers such as basal cell carcinoma. However, its mechanism of activation remains unknown. To this end, we investigate here the sequence of G protein and cholesterol (CHL) ligand binding to SMO on the pathway toward activation. Our results are consistent with the G protein-first activation pathway of SMO in the Hh signaling pathway. In this model, CHL first binds to the cysteine rich domain (CRD) of the inactive SMO, which remains inactive at this stage. The G protein can then spontaneously bind to this SMO, forming a precoupled complex that remains inactive while Patched (PTCH) is attached to the membrane. Upon binding of the Hh ligand to PTCH, the CHL levels in the membrane increase, enabling CHL to also bind to the transmembrane domain (TMD) of SMO. With CHL occupying both the CRD and the TMD sites, opening of the G protein becomes energetically favorable, promoting GDP release and initiating downstream G-protein signaling.
Insights
Cholesterol (CHL) binding to Smoothened (SMO) and subsequent G protein interaction initiates the Hedgehog (Hh) signaling pathway. This G protein-first mechanism is crucial for understanding cancer development and targeted therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Signaling
Background:
- The Smoothened (SMO) receptor is vital in the Hedgehog (Hh) signaling pathway.
- SMO is an oncoprotein and a key therapeutic target for cancers like basal cell carcinoma.
- The precise mechanism of SMO activation remains largely unknown.
Purpose of the Study:
- To elucidate the sequential binding events of G protein and cholesterol (CHL) to SMO.
- To determine the order of ligand interactions leading to SMO activation.
- To understand the role of CHL in SMO signaling.
Main Methods:
- Investigated the sequence of G protein and CHL binding to SMO.
- Analyzed the role of CHL in SMO activation through CRD and TMD binding.
- Modeled the G protein-first activation pathway.
Main Results:
- Results support a G protein-first activation model for SMO in the Hh pathway.
- CHL initially binds to the cysteine-rich domain (CRD) of inactive SMO.
- G protein binding to SMO forms a precoupled complex, awaiting Hh ligand interaction with PTCH and increased membrane CHL levels.
- CHL binding to both CRD and transmembrane domain (TMD) sites promotes G protein opening and downstream signaling.
Conclusions:
- The study clarifies the activation mechanism of SMO, involving sequential CHL and G protein binding.
- This G protein-first pathway provides insights into Hh signaling regulation.
- Understanding this mechanism can inform therapeutic strategies for Hh pathway-driven cancers.
Related Concept Videos
G-protein Coupled Receptors
G-protein Coupled Receptors
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical, 7TM, or...
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity
Two...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

